Statistical Calculators › Proportions: One and Two Groups › Confidence Interval for One Proportion: Sample Size
← All Calculators

Proportions: One and Two Groups

Confidence Interval for One Proportion: Sample Size

Find the smallest sample size needed for an exact Clopper–Pearson confidence interval for a single population proportion to reach a specified width or one-sided distance from the sample proportion to the confidence limit, at a stated confidence level.

Confidence Interval Design

Enter the planning proportion, confidence level, interval type, and target width or distance.

Required Sample Size

The result is the smallest integer N for which the exact Clopper–Pearson interval meets the requested width or distance.
Enter the design parameters and click Calculate Sample Size.

Methodology

Using the relationship between the F distribution and the cumulative binomial distribution, the exact (Clopper–Pearson) 100(1 − α)% confidence limits for a proportion p, based on r successes out of n, are equivalently written using the Beta distribution:

Lower limit = Beta−1(α/2; r, n − r + 1)
Upper limit = Beta−1(1 − α/2; r + 1, n − r)
Width = Upper limit − Lower limit

For one-sided limits, α/2 is replaced by α, and the reported quantity is the distance from the planning proportion to the single limit rather than the full two-sided width.

Because the planned sample size is not yet an integer count of successes, the calculator evaluates these Beta quantiles at the continuous count r = P × n directly, rather than rounding r to the nearest integer at each candidate n. This matches the convention used by PASS and avoids a discreteness artifact: rounding r to an integer can make the achieved width behave non-monotonically in n, so that a search which stops at the very first n whose (rounded-r) width dips below the target can land on a value smaller than the one PASS reports. Evaluating r continuously keeps the achieved width monotonically decreasing in n and reproduces PASS's published sample sizes exactly (verified below).

Assumptions

The procedure assumes the future sample proportion will equal the planning value P. If the observed proportion differs from P, the achieved interval width may be narrower or wider than specified.

Worked Examples & Validation

PASS Chapter 115, Example 1, plans a two-sided 95% exact confidence interval with a target width of 0.06 across a range of planning proportions. PASS reports required sample sizes of 417, 715, 928, 1056, and 1098 for P = 0.1, 0.2, 0.3, 0.4, and 0.5 respectively; this calculator reproduces all five exactly, along with PASS's additional target widths of 0.04 (N = 2065 at P = 0.3) and 0.10 (N = 341 at P = 0.3).

PASS Chapter 115, Example 2 (based on Fleiss, Levin & Paik (2003), pp. 22–23), plans a one-sided lower-limit interval with P = 0.92 and a target distance of 0.15104; PASS and this calculator both return N = 25. Example 4 (based on Lachin (2000), p. 19) plans a one-sided upper-limit interval for zero observed events (P = 0) with a target distance of 0.01; PASS and this calculator both return N = 299.

Confidence level = 0.95  ·  P = 0.3  ·  Two-sided target width = 0.06
Required N = 928  ·  Confidence limits ≈ [0.270, 0.330]

References

Fleiss, J. L., Levin, B., Paik, M. C. (2003). Statistical Methods for Rates and Proportions. Third Edition. John Wiley & Sons, New York.

Newcombe, R. G. (1998). Two-Sided Confidence Intervals for the Single Proportion: Comparison of Seven Methods. Statistics in Medicine, 17, 857–872.

Lachin, J. M. (2000). Biostatistical Methods: The Assessment of Relative Risks. John Wiley & Sons, New York.

Hintze, J. L. (2008). PASS User's Guide III. NCSS. Chapter 115, “Confidence Intervals for One Proportion.”

Clinical Trials

Real trials behind this calculation

See the analysis this calculator plans for applied to published trial results, with the estimates, confidence intervals and interpretation explained.

TeenCove
Complete statistical analysis of the TeenCove trial of mRNA-1273 and mRNA-1273.222 in adolescents 12 to
Phase 2/3 · n = 4,328
GALATHEA
Independent statistical analysis of the phase 3 GALATHEA trial of benralizumab 30 mg and 100 mg versus placebo in moderate to very…
Phase 3 · n = 1,656
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs: Complete Statistical Analysis
Independent statistical analysis of A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic…
Phase 3 · n = 670
ENESTPath
Independent statistical analysis of A Randomized Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib…
Phase 3 · n = 620
FLAURA2
Independent statistical analysis of FLAURA2, the randomized phase 3 trial of osimertinib with chemotherapy versus osimertinib alone in first-line treatment of EGFR-mutated…
Phase 3 · n = 587
A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults: Complete Statistical Analysis
Independent statistical analysis of A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With…
Phase 2 · n = 71
See all 800 trials using Exact / Clopper-Pearson binomial →
Clinical Biostats